Fiscal Year ended March 2021 Consolidated Financial Results

May 12, 2021

Index

1.

Consolidated Financial Results

P. 3

2.

Forecasts

P. 9

3.

Shareholders Return

P. 20

4.

The Progress of Mid-term Management

P. 21

Strategy "Accelerate 2025"

5.

References

P. 26

Notes: Apply ASBJ Statement No. 29, Accounting Standard for Revenue Recognition, from the beginning of the fiscal year ending March 2022. The consolidated earnings forecast is the amount after applying the relevant accounting standards, and reference values are listed in the rate of increase / decrease from the previous fiscal year.

Fiscal Year ended March 2021 Consolidated Financial Results

2

1. Consolidated Financial Results

Financial Results

billion yen

20/3

21/3

21/3

Y o Y

vs Forecasts

Change

Change

Results

Forecasts*

Results

Net Sales

412.8

388.0

393.6

-19.3

‐4.7%

+5.6

+1.4%

Operating Income

29.6

28.0

31.7

+2.1

+7.0%

+3.7

+13.3%

Ordinary Income

31.8

29.5

34.7

+2.9

+9.1%

+5.2

+17.6%

Income Attributable to

5.0

18.0

19.7

+14.7

+296.0%

+1.7

+9.5%

Owners of Parent

Exchange Rate USD/JPY

109

106

106

In the fiscal year ended March 2021, although sales declined due to sluggish demand in various industries due to the COVID- 19, the Group has steadily seized sales opportunities due to the recovery of automobile production demand, worked hard to reduce cost, and recovered its business performance over the period. In addition, the factors behind the increase in net income attributable to owners of the parent company were the recording of an extraordinary loss related to structural reforms such as the inflator business in the previous fiscal year, and the acquisition of Polyplastics as a wholly owned subsidiary in October 2020 (ownership ratio 55% to 100%).

Compared to the forecast announced in Feb. 2021, profits exceeded expectations due to price revisions associated with rising acetic acid market conditions and sales expansion in response to product demand recovery.

* The forecasts were announced on February 3, 2021.

Fiscal Year ended March 2021 Consolidated Financial Results

3

1. Consolidated Financial Results

Net Sales and Operating Income by Segment

billion yen

Net Sales

20/3

21/3

21/3

Y o Y

vs Forecasts

Results

Forecasts*

Results

Change

Change

Medical / Healthcare

15.1

15.5

16.2

+1.1

+7.4%

+0.7

+4.6%

Smart

25.3

25.0

24.7

-0.6

-2.6%

-0.3

-1.2%

Safety

74.8

67.0

67.2

-7.6

-10.1%

+0.2

+0.3%

Materials

109.4

100.5

104.2

-5.2

-4.7%

+3.7

+3.7%

Engineering Plastics

176.1

167.5

168.6

-7.6

-4.3%

+1.1

+0.6%

Others

12.1

12.5

12.7

+0.6

+4.9%

+0.2

+1.4%

Total

412.8

388.0

393.6

-19.3

-4.7%

+5.6

+1.4%

Operating Income

20/3

21/3

21/3

Y o Y

vs Forecasts

Results

Forecasts*

Results

Change

Change

Medical / Healthcare

1.3

1.5

1.6

+0.2

+16.6%

+0.1

+4.1%

Smart

3.4

3.0

3.4

+0.1

+1.9%

+0.4

+13.7%

Safety

3.3

2.5

2.2

-1.1

-32.4%

-0.3

-10.8%

Materials

15.8

15.0

17.9

+2.1

+13.3%

+2.9

+19.5%

Engineering Plastics

20.9

19.5

21.2

+0.3

+1.3%

+1.7

+8.6%

Others

0.8

1.5

1.5

+0.7

+82.1%

-0.0

-1.2%

Corporate

-15.9

-15.0

-16.1

-0.2

-1.1%

-1.1

-7.1%

Total

29.6

28.0

31.7

+2.1

+7.0%

+3.7

+13.3%

* The forecasts were announced on February 3, 2021.

Fiscal Year ended March 2021 Consolidated Financial Results

4

1. Consolidated Financial Results

Net Sales and Operating Income by Segment (Y o Y Analysis)

billion yen

Net Sales

20/3

21/3

Change

%

Analysis

Results

Results

Quantity

Prices

Exchange rate Impact

Medical / Healthcare

15.1

16.2

+1.1

+7.4%

+2.3

-1.2

-0.3

Smart

25.3

24.7

-0.6

-2.6%

-0.8

+0.2

-0.1

Safety

74.8

67.2

-7.6

-10.1%

-6.4

-1.2

-1.2

Materials

109.4

104.2

-5.2

-4.7%

-0.7

-4.5

-1.6

Engineering Plastics

176.1

168.6

-7.6

-4.3%

-2.8

-4.8

-2.3

Others

12.1

12.7

+0.6

+4.9%

+0.6

Total

412.8

393.6

-19.3

-4.7%

-7.8

-11.4

-5.5

Operating Income

20/3

21/3

Change

%

Analysis

Quantity

Prices

Exchange rate

Others

Results

Results

Impact

Medical / Healthcare

1.3

1.6

+0.2

+16.6%

+1.1

-0.9

-0.1

-0.0

Smart

3.4

3.4

+0.1

+1.9%

-0.5

+1.5

-0.1

-0.9

Safety

3.3

2.2

-1.1

-32.4%

-5.4

-1.1

-0.1

+5.4

Materials

15.8

17.9

+2.1

+13.3%

-1.3

+1.2

-0.9

+2.2

Engineering Plastics

20.9

21.2

+0.3

+1.3%

+0.2

+1.6

-0.6

-1.5

Others

0.8

1.5

+0.7

+82.1%

+0.7

-

-

-

Corporate

-15.9

-16.1

-0.2

-1.1%

-

-

-

-0.2

Total

29.6

31.7

+2.1

+7.0%

-5.2

+2.3

-1.8

+5.0

Fiscal Year ended March 2021 Consolidated Financial Results

*Exchange rate impact is included in price impact.

5

This is an excerpt of the original content. To continue reading it, access the original document here.

Attachments

  • Original document
  • Permalink

Disclaimer

Daicel Corporation published this content on 12 May 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 12 May 2021 12:39:09 UTC.